Open AccessCorrection of Hepatic Encephalopathy in Patients with Liver Cirrhosis in Combination with Intestinal Dysbiosis
Author(s) -
I. M. Havrysh
Publication year - 2014
Publication title -
bukovinsʹkij medičnij vìsnik
Language(s) - English
Resource type - Journals
eISSN - 2413-0737
pISSN - 1684-7903
DOI - 10.24061/2413-0737.xviii.1.69.2014.5
Subject(s) - cirrhosis , hepatic encephalopathy , dysbiosis , gastroenterology , medicine , encephalopathy , rifaximin , antibiotics , biology , disease , microbiology and biotechnology
65 patients with liver cirrhosis combined with intestinal dysbiosis have been examined; an assessment ofthe functional state of the liver, clinical manifestations of hepatic encephalopathy, neuropsychometric tests, intestinalmicrobiota has been carried out; Lactobacillus and Bifidobacterium as well as Methylsiliconic acid hydrogel were included into the complex treatment. Inclusion of these drugs in the complex treatment resulted in significantly better reduction of subjective and objective signs of cirrhosis, severity of functional and biochemical syndromes, symptoms of hepatic encephalopathy.